TMEM266
gene geneOn this page
Also known as FLJ38190
Summary
TMEM266 (transmembrane protein 266, HGNC:26763) is a protein-coding gene on chromosome 15q24.2, encoding Transmembrane protein 266 (Q2M3C6). Voltage-sensor protein present on the post-synaptic side of glutamatergic mossy fibers and granule cells in the cerebellum.
Enables protein homodimerization activity. Predicted to be involved in transmembrane transport. Located in cytosol; dendrite; and plasma membrane.
Source: NCBI Gene 123591 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 93 total
- MANE Select transcript:
NM_152335
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26763 |
| Approved symbol | TMEM266 |
| Name | transmembrane protein 266 |
| Location | 15q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ38190 |
| Ensembl gene | ENSG00000169758 |
| Ensembl biotype | protein_coding |
| OMIM | 618691 |
| Entrez | 123591 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 4 protein_coding, 2 nonsense_mediated_decay, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000388942, ENST00000484722, ENST00000558249, ENST00000559079, ENST00000561302, ENST00000902737, ENST00000902738, ENST00000902739
RefSeq mRNA: 1 — MANE Select: NM_152335
NM_152335
Canonical transcript exons
ENST00000388942 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001504452 | 76156604 | 76156758 |
| ENSE00001881005 | 76203741 | 76204963 |
| ENSE00002474091 | 76137707 | 76137895 |
| ENSE00002538938 | 76059985 | 76060016 |
| ENSE00002569427 | 76134168 | 76134301 |
| ENSE00003470968 | 76169816 | 76169872 |
| ENSE00003504310 | 76191968 | 76192157 |
| ENSE00003531476 | 76170993 | 76171131 |
| ENSE00003576205 | 76202202 | 76202264 |
| ENSE00003635511 | 76160095 | 76160168 |
| ENSE00003650456 | 76175559 | 76175674 |
Expression profiles
Bgee: expression breadth ubiquitous, 176 present calls, max score 93.91.
FANTOM5 (CAGE): breadth broad, TPM avg 0.6834 / max 149.4574, expressed in 228 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 147838 | 0.4295 | 137 |
| 147837 | 0.2539 | 132 |
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right hemisphere of cerebellum | UBERON:0014890 | 93.91 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 93.83 | gold quality |
| cerebellar cortex | UBERON:0002129 | 93.81 | gold quality |
| cerebellum | UBERON:0002037 | 93.24 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 82.68 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.13 | gold quality |
| muscle of leg | UBERON:0001383 | 78.90 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.56 | gold quality |
| gastrocnemius | UBERON:0001388 | 78.33 | gold quality |
| cerebellar vermis | UBERON:0004720 | 77.79 | gold quality |
| right frontal lobe | UBERON:0002810 | 76.80 | gold quality |
| body of pancreas | UBERON:0001150 | 76.17 | gold quality |
| prefrontal cortex | UBERON:0000451 | 75.16 | gold quality |
| vastus lateralis | UBERON:0001379 | 74.64 | silver quality |
| right adrenal gland cortex | UBERON:0035827 | 74.40 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 74.38 | gold quality |
| quadriceps femoris | UBERON:0001377 | 74.32 | silver quality |
| right adrenal gland | UBERON:0001233 | 73.68 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 73.00 | gold quality |
| frontal cortex | UBERON:0001870 | 72.70 | gold quality |
| primary visual cortex | UBERON:0002436 | 72.68 | gold quality |
| adrenal tissue | UBERON:0018303 | 72.38 | gold quality |
| pituitary gland | UBERON:0000007 | 72.15 | gold quality |
| neocortex | UBERON:0001950 | 71.97 | gold quality |
| adenohypophysis | UBERON:0002196 | 71.81 | gold quality |
| left adrenal gland | UBERON:0001234 | 71.75 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 71.71 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 71.35 | gold quality |
| muscle tissue | UBERON:0002385 | 70.55 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 70.28 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-111727 | yes | 141.54 |
| E-ANND-3 | yes | 5.52 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
48 targeting TMEM266, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-MIR-605-3P | 99.88 | 69.22 | 1833 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-148A-3P | 99.74 | 73.77 | 1700 |
| HSA-MIR-148B-3P | 99.74 | 73.75 | 1700 |
| HSA-MIR-152-3P | 99.74 | 73.75 | 1703 |
| HSA-MIR-378G | 99.71 | 64.90 | 1106 |
| HSA-MIR-5004-5P | 99.68 | 66.63 | 1294 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-24-3P | 99.59 | 69.97 | 1934 |
| HSA-MIR-7844-5P | 99.55 | 68.56 | 1428 |
| HSA-MIR-1224-5P | 99.48 | 65.59 | 803 |
| HSA-MIR-1207-3P | 98.99 | 66.22 | 1532 |
| HSA-MIR-224-3P | 98.91 | 68.42 | 1815 |
| HSA-MIR-522-3P | 98.91 | 68.56 | 1817 |
| HSA-MIR-4709-3P | 98.88 | 68.04 | 1594 |
| HSA-MIR-29B-1-5P | 98.86 | 68.35 | 1364 |
| HSA-MIR-873-5P | 98.84 | 66.90 | 1348 |
| HSA-MIR-4635 | 98.74 | 67.63 | 1339 |
| HSA-MIR-330-5P | 98.73 | 67.63 | 1788 |
| HSA-MIR-6840-3P | 98.68 | 65.95 | 1923 |
| HSA-MIR-323A-5P | 98.59 | 65.13 | 651 |
Literature-anchored findings (GeneRIF, showing 2)
- Results identified HVRP1, a voltage sensing domains-containing protein primarily expressed in the central nervous system with high expression in cerebellar tissues particularly in the granule layer. (PMID:25165868)
- Here the authors show that hTMEM266 forms oligomers, undergoes both rapid (micros) and slow (ms) structural rearrangements in response to changes in voltage, and contains a Zn(2+) binding site that can regulate the slow conformational transition. Our results demonstrate that the S1-S4 domain in hTMEM266 is a functional voltage sensor. (PMID:30810529)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem266 | ENSDARG00000101297 |
| mus_musculus | Tmem266 | ENSMUSG00000032313 |
| rattus_norvegicus | Tmem266 | ENSRNOG00000015201 |
Paralogs (6): TNS1 (ENSG00000079308), HVCN1 (ENSG00000122986), TPTE2 (ENSG00000132958), TNS3 (ENSG00000136205), PTEN (ENSG00000171862), TPTE (ENSG00000274391)
Protein
Protein identifiers
Transmembrane protein 266 — Q2M3C6 (reviewed: Q2M3C6)
Alternative names: HV1-related protein 1
All UniProt accessions (3): Q2M3C6, H0YNC9, H3BM28
UniProt curated annotations — full annotation on UniProt →
Function. Voltage-sensor protein present on the post-synaptic side of glutamatergic mossy fibers and granule cells in the cerebellum. Despite the presence of a voltage-sensor segment, does not form a functional ion channel and its precise role remains unclear. Undergoes both rapid and slow structural rearrangements in response to changes in voltage. Contains a zinc-binding site that can regulate the slow conformational transition.
Subunit / interactions. Homodimer; disulfide-linked.
Subcellular location. Cell membrane. Cell projection. Dendrite. Perikaryon.
Tissue specificity. Mainly expressed in the cerebellum. Also expressed in cerebral cortex, skeletal muscle and thyroid, but at much lower levels.
Domain organisation. The transmembrane segment S4 functions as a voltage-sensor and is characterized by a series of positively charged amino acids at every third position. Transplantation of the transmembrane segment S4 into HVCN1, generates a functional voltage-activated proton channel. The coiled coil mediates homodimerization.
RefSeq proteins (1): NP_689548* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005821 | Ion_trans_dom | Domain |
| IPR027359 | Volt_channel_dom_sf | Homologous_superfamily |
| IPR042857 | TMEM266 | Family |
Pfam: PF00520
UniProt features (23 total): mutagenesis site 6, topological domain 5, transmembrane region 4, compositionally biased region 3, sequence variant 2, chain 1, region of interest 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q2M3C6-F1 | 54.53 | 0.06 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (6):
| Position | Phenotype |
|---|---|
| 103–108 | despite residues related to hvcn1 channel, does not show ion channel activity; when associated with 151-m–i-145, a-167, |
| 143–145 | despite residues related to hvcn1 channel, does not show ion channel activity; when associated with 111-d–l-108, a-167, |
| 167 | despite residues related to hvcn1 channel, does not show ion channel activity; when associated with 111-d–l-108, 151-m- |
| 176–177 | despite residues related to hvcn1 channel, does not show ion channel activity; when associated with 111-d–l-108, 151-m- |
| 205 | despite residues related to hvcn1 channel, does not show ion channel activity; when associated with 111-d–l-108, 151-m- |
| 209–214 | despite residues related to hvcn1 channel, does not show ion channel activity; when associated with 111-d–l-108, 151-m- |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 75 (showing top):
TGGTGCT_MIR29A_MIR29B_MIR29C, TAATAAT_MIR126, CAGCAGG_MIR370, GOCC_NEURON_PROJECTION, CAGCCTC_MIR4855P, LEIN_CEREBELLUM_MARKERS, GOCC_CELL_BODY, GOCC_SOMATODENDRITIC_COMPARTMENT, GOCC_PERIKARYON, GOMF_PROTEIN_DIMERIZATION_ACTIVITY, GOMF_GATED_CHANNEL_ACTIVITY, GOMF_PROTEIN_HOMODIMERIZATION_ACTIVITY, GOMF_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_TRANSPORTER_ACTIVITY, DURAND_STROMA_NS_UP
GO Biological Process (1): transmembrane transport (GO:0055085)
GO Molecular Function (3): protein homodimerization activity (GO:0042803), protein binding (GO:0005515), voltage-gated channel activity (GO:0022832)
GO Cellular Component (6): cytosol (GO:0005829), plasma membrane (GO:0005886), dendrite (GO:0030425), perikaryon (GO:0043204), membrane (GO:0016020), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| transport | 1 |
| cellular process | 1 |
| identical protein binding | 1 |
| protein dimerization activity | 1 |
| binding | 1 |
| gated channel activity | 1 |
| cytoplasm | 1 |
| membrane | 1 |
| cell periphery | 1 |
| neuron projection | 1 |
| dendritic tree | 1 |
| neuronal cell body | 1 |
Protein interactions and networks
STRING
406 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM266 | TMEM268 | Q5VZI3 | 618 |
| TMEM266 | SLC35F4 | A4IF30 | 591 |
| TMEM266 | TPTE2 | Q6XPS3 | 489 |
| TMEM266 | ESPNL | Q6ZVH7 | 475 |
| TMEM266 | ETF1 | P46055 | 439 |
| TMEM266 | SPATA24 | Q86W54 | 436 |
| TMEM266 | ETFA | P13804 | 428 |
| TMEM266 | ISL2 | Q96A47 | 425 |
| TMEM266 | TPTE | P56180 | 416 |
| TMEM266 | DNAJC18 | Q9H819 | 415 |
| TMEM266 | YEATS4 | O95619 | 413 |
| TMEM266 | ATP6V1C1 | P21283 | 408 |
| TMEM266 | C2CD2 | Q9Y426 | 405 |
| TMEM266 | AKNAD1 | Q5T1N1 | 397 |
| TMEM266 | ZNF780A | O75290 | 395 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KDM1A | TMEM266 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TMEM266 | KDM1A | psi-mi:“MI:0914”(association) | 0.670 |
| MEOX2 | TMEM266 | psi-mi:“MI:0915”(physical association) | 0.560 |
| WDR5B | TCP1 | psi-mi:“MI:0914”(association) | 0.530 |
| ESR1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| KDM1A | TMEM266 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MEOX2 | TMEM266 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (25): RABEP1 (Affinity Capture-MS), VPS11 (Affinity Capture-MS), TGFBRAP1 (Affinity Capture-MS), STX5 (Affinity Capture-MS), FBXO28 (Affinity Capture-MS), EDRF1 (Affinity Capture-MS), WDR20 (Affinity Capture-MS), HM13 (Affinity Capture-MS), KCMF1 (Affinity Capture-MS), KDM1A (Affinity Capture-MS), C15orf27 (Two-hybrid), C15orf27 (Two-hybrid), C15orf27 (Affinity Capture-MS), WDR20 (Affinity Capture-MS), C15orf27 (Affinity Capture-MS)
ESM2 similar proteins: A0JNG6, A2AKB4, A7YWL5, B0BN13, O35181, O43734, O70142, O70240, O88286, O88566, P0DPB3, P0DPB4, P56975, P70298, P86174, P97303, Q00IB7, Q1LY51, Q2M3C6, Q2T9L4, Q3TY60, Q498S6, Q4V7B1, Q568Z1, Q5HZN9, Q5JTD0, Q5SYB0, Q5U5E5, Q5VT97, Q69ZB8, Q6PG95, Q6UXB0, Q6ZU67, Q76N89, Q80YE4, Q86XD5, Q8BWU3, Q8BZB3, Q8CD60, Q8N365
Diamond homologs: Q1JV40, Q2M3C6, Q3U2S8, Q5F4C0, Q5M7E9, Q5M8L8, Q6DHQ1, Q96D96, Q9N0B5, Q8BZB3, Q4R6N0, Q6XPS3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
93 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 80 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3057 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:76060013:GCAG:G | donor_gain | 1.0000 |
| 15:76060014:CAGG:C | donor_loss | 1.0000 |
| 15:76060015:AGGT:A | donor_loss | 1.0000 |
| 15:76060017:G:C | donor_loss | 1.0000 |
| 15:76060018:T:A | donor_loss | 1.0000 |
| 15:76077367:T:G | acceptor_gain | 1.0000 |
| 15:76134302:G:GG | donor_gain | 1.0000 |
| 15:76137700:A:AG | acceptor_gain | 1.0000 |
| 15:76137701:A:G | acceptor_gain | 1.0000 |
| 15:76137705:A:AG | acceptor_gain | 1.0000 |
| 15:76137705:AG:A | acceptor_gain | 1.0000 |
| 15:76137706:G:GC | acceptor_gain | 1.0000 |
| 15:76137706:GG:G | acceptor_gain | 1.0000 |
| 15:76137706:GGC:G | acceptor_gain | 1.0000 |
| 15:76137706:GGCC:G | acceptor_gain | 1.0000 |
| 15:76137706:GGCCT:G | acceptor_gain | 1.0000 |
| 15:76137891:GAAGG:G | donor_gain | 1.0000 |
| 15:76137893:AGG:A | donor_gain | 1.0000 |
| 15:76137894:GG:G | donor_gain | 1.0000 |
| 15:76137894:GGG:G | donor_gain | 1.0000 |
| 15:76137895:GG:G | donor_gain | 1.0000 |
| 15:76137896:G:GG | donor_gain | 1.0000 |
| 15:76156757:GT:G | donor_gain | 1.0000 |
| 15:76169812:TCAGA:T | acceptor_loss | 1.0000 |
| 15:76169813:CAG:C | acceptor_loss | 1.0000 |
| 15:76169814:A:AG | acceptor_gain | 1.0000 |
| 15:76169814:A:T | acceptor_loss | 1.0000 |
| 15:76169815:G:GG | acceptor_gain | 1.0000 |
| 15:76169815:GACT:G | acceptor_gain | 1.0000 |
| 15:76169869:AGAGG:A | donor_loss | 1.0000 |
AlphaMissense
3493 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:76160136:A:C | S142R | 0.999 |
| 15:76160138:C:A | S142R | 0.999 |
| 15:76160138:C:G | S142R | 0.999 |
| 15:76191984:T:C | L262P | 0.999 |
| 15:76171083:A:C | S202R | 0.998 |
| 15:76171085:C:A | S202R | 0.998 |
| 15:76171085:C:G | S202R | 0.998 |
| 15:76171030:C:G | P184R | 0.997 |
| 15:76156732:T:C | L119P | 0.996 |
| 15:76171000:A:T | D174V | 0.996 |
| 15:76171027:C:A | A183D | 0.996 |
| 15:76171030:C:A | P184Q | 0.996 |
| 15:76171065:A:C | S196R | 0.996 |
| 15:76171067:C:A | S196R | 0.996 |
| 15:76171067:C:G | S196R | 0.996 |
| 15:76171071:T:A | W198R | 0.996 |
| 15:76171071:T:C | W198R | 0.996 |
| 15:76175649:T:C | L248P | 0.996 |
| 15:76191996:T:C | L266P | 0.996 |
| 15:76169826:G:C | R156P | 0.995 |
| 15:76171002:G:A | G175R | 0.995 |
| 15:76171002:G:C | G175R | 0.995 |
| 15:76171107:T:A | W210R | 0.995 |
| 15:76171107:T:C | W210R | 0.995 |
| 15:76171000:A:C | D174A | 0.994 |
| 15:76171003:G:A | G175E | 0.994 |
| 15:76191968:T:C | F257L | 0.994 |
| 15:76191970:T:A | F257L | 0.994 |
| 15:76191970:T:G | F257L | 0.994 |
| 15:76156720:T:C | L115P | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000026071 (15:76067632 C>A,G,T), RS1000026396 (15:76174636 A>G), RS1000058104 (15:76167738 C>A,T), RS1000072277 (15:76069422 A>G), RS1000098177 (15:76133247 A>G), RS1000117433 (15:76140910 A>G), RS1000124591 (15:76109576 C>T), RS1000131496 (15:76076374 C>T), RS1000149913 (15:76090973 C>G), RS1000169386 (15:76067276 C>G,T), RS1000217643 (15:76190858 C>A,T), RS1000219031 (15:76092643 C>G), RS1000220283 (15:76176828 TGGCCTCAGGGTTGAGGTCTCATGTGGCGTACA>T), RS1000232989 (15:76158529 C>T), RS1000248379 (15:76184725 C>T)
Disease associations
OMIM: gene MIM:618691 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007876_30 | Estimated glomerular filtration rate | 3.000000e-25 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression, increases expression | 5 |
| Tobacco Smoke Pollution | decreases expression, decreases methylation | 2 |
| FR900359 | increases phosphorylation | 1 |
| bufotalin | decreases expression | 1 |
| lasiocarpine | decreases expression | 1 |
| methyleugenol | decreases expression | 1 |
| propionaldehyde | increases expression | 1 |
| benzo(e)pyrene | affects methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| abrine | decreases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Cisplatin | decreases expression, affects cotreatment | 1 |
| Dimethyl Sulfoxide | affects expression | 1 |
| Lead | affects expression | 1 |
| Methapyrilene | affects methylation | 1 |
| Nickel | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.